Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05356520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 8, 2024 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv6
  2. Study site revisedv5
  3. Interventions: Esophageal hiatus approach through abdominal diaphragm (Procedure), Ivor-lewis right chest approach (Procedure) to Endoscopy Ivor-lewis (Procedure), Laparoscopic transabdominal enlarged gastrectomy (Procedure)
    • Study description shortened, about 38 words
    • Eligibility criteria expanded, about 3 words
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  5. Secondary endpoints: 5 to 4v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The incidence of esophagogastric junction has been increasing in recent years, and surgery is an important method for the treatment of adenoma at the esophagogastric junction. Currently, there is a great controversy about the surgical method of Siewert II, mainly choosing the right chest or the left chest for thoracic surgery. Therefore, it is of great significance to further study the surgical methods of Siewert II esophagogastric junction adenoma. Objective: To compare the safety, feasibility, and clinical efficacy of endoscopic Ivor-Lewis versus laparoscopic extended abdominal gastrectomy for Siewert type Ⅱadenocarcinoma at the resectable esophagogastric junction.
Trial Details
NCT Number NCT05356520
Lead Sponsor Xijing Hospital of Digestive Diseases
Collaborators: Tang-Du Hospital, Henan Provincial People's Hospital, General Hospital of Ningxia Medical University, First Affiliated Hospital Xi'an Jiaotong University, The First Affiliated Hospital of Shanxi Medical University
Conditions
(from sponsor)		 Siewert Type II Adenocarcinoma of Esophagogastric Junction
Enrollment 212 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov